[1]
Hofmann, PhD, J.F., Lal, MSc, MBA, A., Steffens, M. and Boettger, R. 2016. Patient-relevant outcomes and health-related quality of life in patients with chronic, severe, noncancer pain treated with tapentadol prolonged release—Using criteria of health technology assessment. Journal of Opioid Management. 12, 5 (Sep. 2016), 323–331. DOI:https://doi.org/10.5055/jom.2016.0349.